ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2024

Cost consequence analysis of adding semaglutide to treatment regimen for patients with Type II diabetes in Saudi Arabia.

Yazed AlRuthia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.